CD274 and breast carcinoma: In a mesenchymal breast cancer cell line, a mesenchymal-to-epithelial reversion induced by upregulation of an EMT suppressor microRNA miR-200 [117] also suppressed PD-L1 expression and led to greater CD8+ T cell cytotoxicity.